All News #Library
Biotech
Adcytherix Doses First Patient in Phase 1 ADCX-020 Trial
31 Mar 2026 //
GLOBENEWSWIRE
Adcytherix Secures EUR 105M Series A For Advancing Antibody-Drug
16 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support